PAM
AEGR

Panagora Asset Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Panagora Asset Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,479
Closed -$136K – 2387
2015
Q4 		$136K Buy
13,479
+11,546
+597% +$139K ﹤0.01% 1706
2015
Q3 		$26K Buy
1,933
+423
+28% +$7.53K ﹤0.01% 2108
2015
Q2 		$29K Sell
1,510
-3,664
-71% -$79.3K ﹤0.01% 2245
2015
Q1 		$135K Buy
+5,174
New +$132K ﹤0.01% 1839
2013
Q4 		– Sell
-447
Closed -$38K – 2313
2013
Q3 		$38K Buy
+447
New +$37.9K ﹤0.01% 2083

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Panagora Asset Management's AEGR Position: Q1 2016 in Review

Panagora Asset Management sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2016, closing a stake of 13,479 shares — an estimated $136K sold.

Panagora Asset Management first reported a position in AEGR in Q3 2013 and held it in 5 quarters. The position peaked at $136K in Q4 2015. 101 funds tracked by Wall St. Rank hold AEGR as of Q1 2016.

  • Panagora Asset Management reported no remaining Aegerion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Panagora Asset Management sold 13,479 Aegerion Pharmaceuticals shares in Q1 2016, an estimated $136K.
  • Panagora Asset Management first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Panagora Asset Management's Aegerion Pharmaceuticals position peaked at $136K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2016.

Based on Panagora Asset Management's 13F filing for Q1 2016, filed 16 May 2016.